EUVIMEDEUVIMED entdecken
Crossref

Effects of tDCS on glutamatergic pathways in epilepsy: neuroprotective and therapeutic potential

Filiz Demirdogen, Guven Akcay iD

Pflügers Archiv - European Journal of Physiology · 2025

DOI: 10.1007/s00424-024-03049-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pflügers Archiv - European Journal of Physiology, 2025. Verfasst von Filiz Demirdogen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mengücek Gazi Education and Research Hospital, Binali Yıldırım University, Erzincan, Turkey. Hauptthemen laut MEDLINE: Glutamic Acid, Transcranial Direct Current Stimulation, Epilepsy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Türkiye Sağlık Enstitüleri Başkanlığı.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy is a chronic neurological disease characterized by recurrent seizures caused by abnormal electrical activity in the brain. The aim of our study was to investigate the effect of tDCS on oxidative stress, Ca2+, glutamate, GABA, AMPAR1, and NMDAR1 levels in kindling-induced epilepsy model. Behavioral tests evaluated motor and cognitive functions, while assessing oxidative stress, Ca2+, glutamate, GABA, AMPAR1, and NMDAR1 levels in hippocampal tissue. tDCS stimulation therapy demonstrates a neuroprotective effect on motor and cognitive function postepilepsy. Our study reveals an increase in TOC, Ca2+, glutamate, GABA, AMPAR1, and NMDAR1 levels and a decline in total antioxidant capacity (TAC) following PTZ-induced seizures. However, tDCS treatment led to a significant decrease of Ca2+, total oxidant capacity (TOC), glutamate, GABA, AMPAR1, and NMDAR1 levels in the epilepsy cohorts, while simultaneously causing a spike in TAC levels. The study's results showed that tDCS treatment could have a therapeutic effect on oxidative stress, Ca2+, TOC, glutamate, GABA, AMPAR1, NMDAR1, and TAC in both acute and chronic kindling epilepsy models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glutamic AcidTranscranial Direct Current StimulationEpilepsyAnimalsMaleOxidative StressReceptors, N-Methyl-D-AspartateHippocampusRatsCalciumgamma-Aminobutyric AcidReceptors, AMPAKindling, Neurologic

Stichwörter der Autor:innen

AMPAR1GABAGlutamateHippocampusNMDAR1TDCS

Substanzen

Glutamic AcidReceptors, N-Methyl-D-AspartateCalciumgamma-Aminobutyric AcidReceptors, AMPA

Autor:innen und Institutionen

  • Department of Neurology, Mengücek Gazi Education and Research Hospital, Binali Yıldırım University, Erzincan, Turkey.
  • Department of Biophysics, Faculty of Medicine, Bolu Abant İzzet Baysal University, Bolu, Turkey. guvenakcayibu@gmail.com.
  • Scientific Industrial and Technological Application and Research Center, Bolu Abant Izzet Baysal University, Bolu, Turkey. guvenakcayibu@gmail.com.

ORCID-Profile: Guven Akcay

Förderung

  • Türkiye Sağlık Enstitüleri Başkanlığı

Zitieren

APA

Demirdogen, F., & Akcay, G. (2025). Effects of tDCS on glutamatergic pathways in epilepsy: neuroprotective and therapeutic potential. Pflügers Archiv - European Journal of Physiology. https://doi.org/10.1007/s00424-024-03049-1

Vancouver

Demirdogen F, Akcay G. Effects of tDCS on glutamatergic pathways in epilepsy: neuroprotective and therapeutic potential. Pflügers Archiv - European Journal of Physiology. 2025. doi:10.1007/s00424-024-03049-1

BibTeX
@article{Demirdogen2025,
  author = {Demirdogen, Filiz and Akcay, Guven},
  title = {Effects of tDCS on glutamatergic pathways in epilepsy: neuroprotective and therapeutic potential},
  journal = {Pflügers Archiv - European Journal of Physiology},
  year = {2025},
  doi = {10.1007/s00424-024-03049-1}
}
Kostenlos starten →